{
  "primary": "ATXN3",
  "interaction_type": "direct",
  "upstream_interactor": null,
  "mediator_chain": [],
  "depth": 1,
  "support_summary": "ATXN3 physically binds and deubiquitinates YAP1, a key effector of the Hippo pathway, to promote cancer metastasis (Co-IP, deubiquitination assay evidence).",
  "functions": [
    {
      "function": "YAP1 Protein Stability & Hippo Signaling",
      "arrow": "activates",
      "cellular_process": "ATXN3 directly interacts with, deubiquitinates, and stabilizes the Hippo pathway effector YAP1. The interaction is mediated by the Josephin domain of ATXN3 and the WW domain of YAP1. By removing K48-linked polyubiquitin chains from YAP1, ATXN3 prevents its proteasomal degradation.",
      "effect_description": "The stabilization of YAP1 by ATXN3 leads to its increased protein abundance, nuclear accumulation, and enhanced transcriptional activity. This results in the upregulation of YAP1/TEAD target genes, which promotes cancer cell proliferation, invasion, and metastasis.",
      "biological_consequence": [
        "ATXN3's Josephin domain binds to YAP1's WW domain → ATXN3 removes K48-linked polyubiquitin chains from YAP1 → YAP1 degradation by the proteasome is inhibited → YAP1 protein accumulates and translocates to the nucleus → YAP1 co-activates TEAD transcription factors → Upregulation of target genes (e.g., CTGF, ANKRD1, CYR61) → Promotion of cell proliferation and metastasis."
      ],
      "specific_effects": [
        "Direct deubiquitination of YAP1",
        "Inhibition of K48-specific polyubiquitination of YAP1",
        "Increased YAP1 protein half-life and stability",
        "Increased nuclear localization of YAP1",
        "Enhanced expression of YAP/TEAD target genes"
      ],
      "evidence": [
        {
          "paper_title": "ATXN3 promotes prostate cancer progression by stabilizing YAP",
          "journal": "Cell Communication and Signaling",
          "year": 2023,
          "relevant_quote": "ATXN3 was shown to interact with, deubiquitylate, and stabilize YAP in a deubiquitylation activity-dependent manner. Depletion of ATXN3 decreased the YAP protein level and the expression of YAP/TEAD target genes in PC, including CTGF, ANKRD1 and CYR61. Further mechanistic study revealed that the Josephin domain of ATXN3 interacted with the WW domain of YAP. ATXN3 stabilized YAP protein via inhibiting K48-specific poly-ubiquitination process on YAP protein.",
          "pmid": "37349820"
        }
      ],
      "pmids": [
        "37349820"
      ],
      "interaction_effect": "activates",
      "interaction_direction": "main_to_primary",
      "function_effect": "activation"
    }
  ],
  "arrow": "activates",
  "direction": "primary_to_main",
  "intent": "regulation",
  "arrows": {
    "main_to_primary": [
      "activates"
    ]
  },
  "is_valid": true,
  "mechanism_correction": null,
  "mechanism": "ATXN3 directly interacts with, deubiquitinates, and stabilizes the Hippo pathway effector YAP1. The interaction is mediated by the Josephin domain of ATXN3 and the WW domain of YAP1. By removing K48-linked polyubiquitin chains from YAP1, ATXN3 prevents its proteasomal degradation.",
  "effect": "The stabilization of YAP1 by ATXN3 leads to its increased protein abundance, nuclear accumulation, and enhanced transcriptional activity. This results in the upregulation of YAP1/TEAD target genes, which promotes cancer cell proliferation, invasion, and metastasis.",
  "summary": "ATXN3 activates YAP1 to modulate yap1 protein stability & hippo signaling, ultimately affecting promotion of cell proliferation and metastasis.",
  "evidence": [
    {
      "paper_title": "ATXN3 promotes prostate cancer progression by stabilizing YAP",
      "journal": "Cell Communication and Signaling",
      "year": 2023,
      "relevant_quote": "ATXN3 was shown to interact with, deubiquitylate, and stabilize YAP in a deubiquitylation activity-dependent manner. Depletion of ATXN3 decreased the YAP protein level and the expression of YAP/TEAD target genes in PC, including CTGF, ANKRD1 and CYR61. Further mechanistic study revealed that the Josephin domain of ATXN3 interacted with the WW domain of YAP. ATXN3 stabilized YAP protein via inhibiting K48-specific poly-ubiquitination process on YAP protein."
    }
  ],
  "initial_pathway": {
    "pathway_name": "Hippo signaling pathway",
    "confidence": 0.95,
    "reasoning": "ATXN3 deubiquitinates and stabilizes YAP1, the primary transcriptional effector of the Hippo signaling pathway, promoting cancer progression."
  },
  "interaction_effect": "activation",
  "_validation_metadata": {
    "validated": true,
    "validator": "arrow_effect_validator",
    "corrections_applied": 1
  },
  "_arrow_validated": true,
  "arrow_notation": "ATXN3 --activates--> YAP1:",
  "protein_a": "YAP1",
  "protein_b": "ATXN3",
  "discovered_in_query": "ATXN3",
  "first_discovered": "2025-12-19T07:06:31.361725Z",
  "last_updated": "2025-12-19T07:06:31.361725Z"
}